OpenURL Connection Search

Select item for more details and to access through your institution.

Protein secondary structure in spider silk nanofibrils.
Published in:
Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-31883-3
By:
- Wang, Qijue;
- McArdle, Patrick;
- Wang, Stephanie L.;
- Wilmington, Ryan L.;
- Xing, Zhen;
- Greenwood, Alexander;
- Cotten, Myriam L.;
- Qazilbash, M. Mumtaz;
- Schniepp, Hannes C.
Publication type:
Article
Electronic correlations in the iron pnictides.
Published in:
Nature Physics, 2009, v. 5, n. 9, p. 647, doi. 10.1038/nphys1343
By:
- Qazilbash, M. M.;
- Hamlin, J. J.;
- Baumbach, R. E.;
- Zhang, Lijun;
- Singh, D. J.;
- Maple, M. B.;
- Basov, D. N.
Publication type:
Article
Insulator-to-metal transition in ultrathin rutile VO2/TiO2(001).
Published in:
NPJ Quantum Materials, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41535-022-00479-x
By:
- Lahneman, D. J.;
- Slusar, Tetiana;
- Beringer, D. B.;
- Jiang, Haoyue;
- Kim, Chang-Yong;
- Kim, Hyun-Tak;
- Qazilbash, M. M.
Publication type:
Article
Insulator-to-metal transition in ultrathin rutile VO2/TiO2(001).
Published in:
NPJ Quantum Materials, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41535-022-00479-x
By:
- Lahneman, D. J.;
- Slusar, Tetiana;
- Beringer, D. B.;
- Jiang, Haoyue;
- Kim, Chang-Yong;
- Kim, Hyun-Tak;
- Qazilbash, M. M.
Publication type:
Article
Enhanced superconductivity in aluminum-based hyperbolic metamaterials.
Published in:
Scientific Reports, 2016, p. 34140, doi. 10.1038/srep34140
By:
- Smolyaninova, Vera N.;
- Jensen, Christopher;
- Zimmerman, William;
- Prestigiacomo, Joseph C.;
- Osofsky, Michael S.;
- Kim, Heungsoo;
- Bassim, Nabil;
- Xing, Zhen;
- Qazilbash, Mumtaz M.;
- Smolyaninov, Igor I.
Publication type:
Article
Cancer gene therapy using a novel adeno-associated virus vector expressing human wild-type p53.
Published in:
Gene Therapy, 1997, v. 4, n. 7, p. 675, doi. 10.1038/sj.gt.3300444
By:
- Qazilbash, M H;
- Xiao, X;
- Seth, P;
- Cowan, K H;
- Walsh, C E
Publication type:
Article
High-dose therapy with auto-SCT is feasible in high-risk cardiac amyloidosis.
Published in:
Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 668, doi. 10.1038/bmt.2015.21
By:
- Kongtim, P;
- Qazilbash, M H;
- Shah, J J;
- Hamdi, A;
- Shah, N;
- Bashir, Q;
- Wang, M;
- Champlin, R;
- Manasanch, E E;
- Weber, D;
- Orlowski, R Z;
- Parmar, S
Publication type:
Article
Auto-SCT improves survival in systemic light chain amyloidosis: a retrospective analysis with 14-year follow-up.
Published in:
Bone Marrow Transplantation, 2014, v. 49, n. 8, p. 1036, doi. 10.1038/bmt.2014.115
By:
- Parmar, S;
- Kongtim, P;
- Champlin, R;
- Dinh, Y;
- Elgharably, Y;
- Wang, M;
- Bashir, Q;
- Shah, J J;
- Shah, N;
- Popat, U;
- Giralt, S A;
- Orlowski, R Z;
- Qazilbash, M H
Publication type:
Article
Durable responses with autologous hematopoietic SCT in patients with POEMS syndrome.
Published in:
Bone Marrow Transplantation, 2014, v. 49, n. 3, p. 465, doi. 10.1038/bmt.2013.209
By:
- Patel, K;
- Nusrat, M;
- Shah, N;
- Bashir, Q;
- Parmar, S;
- Shah, J;
- Thomas, S;
- Weber, D;
- Orlowski, R Z;
- Champlin, R;
- Qazilbash, M H
Publication type:
Article
Value of novel agents and intensive therapy for patients with multiple myeloma.
Published in:
Bone Marrow Transplantation, 2014, v. 49, n. 3, p. 422, doi. 10.1038/bmt.2013.189
By:
- Alexanian, R;
- Wang, M;
- Delasalle, K;
- Wang, S;
- Qazilbash, M;
- Handy, B;
- Weber, D
Publication type:
Article
Adenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience.
Published in:
Bone Marrow Transplantation, 2013, v. 48, n. 9, p. 1218, doi. 10.1038/bmt.2013.33
By:
- Yilmaz, M;
- Chemaly, R F;
- Han, X Y;
- Thall, P F;
- Fox, P S;
- Tarrand, J J;
- De Lima, M J;
- Hosing, C M;
- Popat, U R;
- Shpall, E;
- Champlin, R E;
- Qazilbash, M H
Publication type:
Article
Outcomes of second allogeneic hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia.
Published in:
Bone Marrow Transplantation, 2013, v. 48, n. 5, p. 666, doi. 10.1038/bmt.2012.195
By:
- Poon, L M;
- Bassett Jr, R;
- Rondon, G;
- Hamdi, A;
- Qazilbash, M;
- Hosing, C;
- Jones, R B;
- Shpall, E J;
- Popat, U R;
- Nieto, Y;
- Worth, L L;
- Cooper, L;
- De Lima, M;
- Champlin, R E;
- Kebriaei, P
Publication type:
Article
Neoantigen and tumor antigen-specific immunity transferred from immunized donors is detectable early after allogeneic transplantation in myeloma patients.
Published in:
Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 269, doi. 10.1038/bmt.2012.132
By:
- Foglietta, M;
- Neelapu, S S;
- Kwak, L W;
- Jiang, Y;
- Nattamai, D;
- Lee, S-T;
- Fowler, D H;
- Sportes, C;
- Gress, R E;
- Steinberg, S M;
- Vence, L M;
- Radvanyi, L;
- Dwyer, K C;
- Qazilbash, M H;
- Bryant, R N K;
- Bishop, M R
Publication type:
Article
Intravenous BU plus Mel: an effective, chemotherapy-only transplant conditioning regimen in patients with ALL.
Published in:
Bone Marrow Transplantation, 2013, v. 48, n. 1, p. 26, doi. 10.1038/bmt.2012.114
By:
- Kebriaei, P;
- Madden, T;
- Wang, X;
- Thall, P F;
- Ledesma, C;
- de Lima, M;
- Shpall, E J;
- Hosing, C;
- Qazilbash, M;
- Popat, U;
- Alousi, A;
- Nieto, Y;
- Champlin, R E;
- Jones, R B;
- Andersson, B S
Publication type:
Article
Long-term outcome of reduced-intensity allogeneic hematopoietic SCT in patients with AML in CR.
Published in:
Bone Marrow Transplantation, 2012, v. 47, n. 2, p. 212, doi. 10.1038/bmt.2011.61
By:
- Popat, U;
- de Lima, M J;
- Saliba, R M;
- Anderlini, P;
- Andersson, B S;
- Alousi, A M;
- Hosing, C;
- Nieto, Y;
- Parmar, S;
- Khouri, I F;
- Kebriaei, P;
- Qazilbash, M;
- Champlin, R E;
- Giralt, S A
Publication type:
Article
Phase II trial of high-dose topotecan, melphalan and CY with autologous stem cell support for multiple myeloma.
Published in:
Bone Marrow Transplantation, 2011, v. 46, n. 4, p. 510, doi. 10.1038/bmt.2010.160
By:
- Kazmi, S. M. A.;
- Saliba, R. M.;
- Donato, M.;
- Wang, M.;
- Hosing, C.;
- Qureshi, S.;
- Anderlini, P.;
- Popat, U.;
- Champlin, R. E.;
- Giralt, S. A.;
- Qazilbash, M. H.
Publication type:
Article
CR represents an early index of potential long survival in multiple myeloma.
Published in:
Bone Marrow Transplantation, 2010, v. 45, n. 3, p. 498, doi. 10.1038/bmt.2009.176
By:
- Wang, M.;
- Delasalle, K.;
- Feng, L.;
- Thomas, S.;
- Giralt, S.;
- Qazilbash, M.;
- Handy, B.;
- Lee, J. J.;
- Alexanian, R.
Publication type:
Article
Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT.
Published in:
Bone Marrow Transplantation, 2010, v. 45, n. 3, p. 429, doi. 10.1038/bmt.2009.189
By:
- Ciurea, S. O.;
- Saliba, R.;
- Rondon, G.;
- Pesoa, S.;
- Cano, P.;
- Fernandez-Vina, M.;
- Qureshi, S.;
- Worth, L. L.;
- McMannis, J.;
- Kebriaei, P.;
- Jones, R. B.;
- Korbling, M.;
- Qazilbash, M.;
- Shpall, E. J.;
- Giralt, S.;
- Lima, M. de;
- Champlin, R. E.;
- Gajewski, J.
Publication type:
Article
Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies.
Published in:
Bone Marrow Transplantation, 2007, v. 40, n. 2, p. 125, doi. 10.1038/sj.bmt.1705699
By:
- Özdemir, E.;
- Saliba, R. M.;
- Champlin, R. E.;
- Couriel, D. R.;
- Giralt, S. A.;
- de Lima, M.;
- Khouri, I. F.;
- Hosing, C.;
- Kornblau, S. M.;
- Anderlini, P.;
- Shpall, E. J.;
- Qazilbash, M. H.;
- Molldrem, J. J.;
- Chemaly, R. F.;
- Komanduri, K. V.
Publication type:
Article
Autologous stem cell transplantation is safe and feasible in elderly patients with multiple myeloma.
Published in:
Bone Marrow Transplantation, 2007, v. 39, n. 5, p. 279, doi. 10.1038/sj.bmt.1705580
By:
- Qazilbash, M. H.;
- Saliba, R. M.;
- Hosing, C.;
- Mendoza, F.;
- Qureshi, S. R.;
- Weber, D. M.;
- Wang, M.;
- Flosser, T.;
- Couriel, D. R.;
- De Lima, M.;
- Kebriaei, P.;
- Popat, U.;
- Alousi, A. M.;
- Champlin, R. E.;
- Giralt, S. A.
Publication type:
Article
Strongyloidiasis after unrelated nonmyeloablative allogeneic stem cell transplantation.
Published in:
2006
By:
- Qazilbash, M. H.;
- Ueno, N. T.;
- Hosing, C.;
- De Lima, M.;
- Cortes, J.;
- Massaro, A.;
- Rivera, Z.;
- Deavers, M.;
- Adachi, J. A.;
- Champlin, R. E.
Publication type:
Letter
Allogeneic hematopoietic stem cell transplantation after rituximab-containing myeloablative preparative regimen for acute lymphoblastic leukemia.
Published in:
Bone Marrow Transplantation, 2006, v. 38, n. 3, p. 203, doi. 10.1038/sj.bmt.1705425
By:
- Kebriaei, P.;
- Saliba, R. M.;
- Ma, C.;
- Ippoliti, C.;
- Couriel, D. R.;
- de Lima, M.;
- Giralt, S.;
- Qazilbash, M. H.;
- Gajewski, J. L.;
- Ha, C. S.;
- Champlin, R. E.;
- Khouri, I. F.
Publication type:
Article
Thiotepa and fractionated TBI conditioning prior to allogeneic stem cell transplantation for advanced hematologic malignancies: a phase II single institution trial.
Published in:
Bone Marrow Transplantation, 2004, v. 34, n. 7, p. 577, doi. 10.1038/sj.bmt.1704642
By:
- Devetten, M. P.;
- Qazilbash, M. H.;
- Beall, C. L.;
- Bunner, P.;
- Weisenborn, R.;
- Lynch, J. P.;
- Ericson, S. G.
Publication type:
Article
The association of diabetes and anti-diabetic medications with clinical outcomes in multiple myeloma.
Published in:
British Journal of Cancer, 2014, v. 111, n. 3, p. 628, doi. 10.1038/bjc.2014.307
By:
- Wu, W;
- Merriman, K;
- Nabaah, A;
- Seval, N;
- Seval, D;
- Lin, H;
- Wang, M;
- Qazilbash, M H;
- Baladandayuthapani, V;
- Berry, D;
- Orlowski, R Z;
- Lee, M-H;
- Yeung, S-C J
Publication type:
Article
Phase I/II trial of lenalidomide and high-dose melphalan with autologous stem cell transplantation for relapsed myeloma.
Published in:
Leukemia (08876924), 2015, v. 29, n. 9, p. 1945, doi. 10.1038/leu.2015.54
By:
- Shah, N;
- Thall, P F;
- Fox, P S;
- Bashir, Q;
- Shah, J J;
- Parmar, S;
- Lin, P;
- Kebriaei, P;
- Nieto, Y;
- Popat, U R;
- Hosing, C M;
- Cornelison, A;
- Shpall, E J;
- Orlowski, R Z;
- Champlin, R E;
- Qazilbash, M H
Publication type:
Article
Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome.
Published in:
2008
By:
- de Lima, M.;
- Champlin, R. E.;
- Thall, P. F.;
- Wang, X.;
- Martin, T. G.;
- Cook, J. D.;
- McCormick, G.;
- Qazilbash, M.;
- Kebriaei, P.;
- Couriel, D.;
- Shpall, E. J.;
- Khouri, I.;
- Anderlini, P.;
- Hosing, C.;
- Chan, K. W.;
- Andersson, B. S.;
- Patah, P. A.;
- Caldera, Z.;
- Jabbour, E.;
- Giralt, S.
Publication type:
journal article
Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation.
Published in:
2007
By:
- Oran, B.;
- Giralt, S.;
- Couriel, D.;
- Hosing, C.;
- Shpall, E. J.;
- de Meis, E.;
- Khouri, I. F.;
- Qazilbash, M.;
- Anderlini, P.;
- Kebriaei, P.;
- Popat, U.;
- Carrasco-Yalan, A.;
- Champlin, R. E.;
- de Lima, M.
Publication type:
Letter
Complete Response after High-Dose Chemotherapy and Autologous Hemopoietic Stem Cell Transplantation in Metastatic Breast Cancer Results in Survival Benefit.
Published in:
2006
By:
- Kurian S;
- Qazilbash M;
- Fay J;
- Wolff S;
- Herzig R;
- Hobbs G;
- Bunner P;
- Weisenborn R;
- Aya-ay M;
- Lynch J;
- Ericson S
Publication type:
Journal Article
On the Optical Properties of Thin‐Film Vanadium Dioxide from the Visible to the Far Infrared.
Published in:
Annalen der Physik, 2019, v. 531, n. 10, p. N.PAG, doi. 10.1002/andp.201900188
By:
- Wan, Chenghao;
- Zhang, Zhen;
- Woolf, David;
- Hessel, Colin M.;
- Rensberg, Jura;
- Hensley, Joel M.;
- Xiao, Yuzhe;
- Shahsafi, Alireza;
- Salman, Jad;
- Richter, Steffen;
- Sun, Yifei;
- Qazilbash, M. Mumtaz;
- Schmidt‐Grund, Rüdiger;
- Ronning, Carsten;
- Ramanathan, Shriram;
- Kats, Mikhail A.
Publication type:
Article

Found: 29

Protein secondary structure in spider silk nanofibrils.

Electronic correlations in the iron pnictides.

Insulator-to-metal transition in ultrathin rutile VO<sub>2</sub>/TiO<sub>2</sub>(001).

Insulator-to-metal transition in ultrathin rutile VO<sub>2</sub>/TiO<sub>2</sub>(001).

Enhanced superconductivity in aluminum-based hyperbolic metamaterials.

Cancer gene therapy using a novel adeno-associated virus vector expressing human wild-type p53.

High-dose therapy with auto-SCT is feasible in high-risk cardiac amyloidosis.

Auto-SCT improves survival in systemic light chain amyloidosis: a retrospective analysis with 14-year follow-up.

Durable responses with autologous hematopoietic SCT in patients with POEMS syndrome.

Value of novel agents and intensive therapy for patients with multiple myeloma.

Adenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience.

Outcomes of second allogeneic hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia.

Neoantigen and tumor antigen-specific immunity transferred from immunized donors is detectable early after allogeneic transplantation in myeloma patients.

Intravenous BU plus Mel: an effective, chemotherapy-only transplant conditioning regimen in patients with ALL.

Long-term outcome of reduced-intensity allogeneic hematopoietic SCT in patients with AML in CR.

Phase II trial of high-dose topotecan, melphalan and CY with autologous stem cell support for multiple myeloma.

CR represents an early index of potential long survival in multiple myeloma.

Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT.

Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies.

Autologous stem cell transplantation is safe and feasible in elderly patients with multiple myeloma.

Strongyloidiasis after unrelated nonmyeloablative allogeneic stem cell transplantation.

Allogeneic hematopoietic stem cell transplantation after rituximab-containing myeloablative preparative regimen for acute lymphoblastic leukemia.

Thiotepa and fractionated TBI conditioning prior to allogeneic stem cell transplantation for advanced hematologic malignancies: a phase II single institution trial.

The association of diabetes and anti-diabetic medications with clinical outcomes in multiple myeloma.

Phase I/II trial of lenalidomide and high-dose melphalan with autologous stem cell transplantation for relapsed myeloma.

Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome.

Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation.

Complete Response after High-Dose Chemotherapy and Autologous Hemopoietic Stem Cell Transplantation in Metastatic Breast Cancer Results in Survival Benefit.

On the Optical Properties of Thin‐Film Vanadium Dioxide from the Visible to the Far Infrared.